标题
Prostaglandin E2 and Cancer: Insight into Tumor Progression and Immunity
作者
关键词
-
出版物
Biology-Basel
Volume 9, Issue 12, Pages 434
出版商
MDPI AG
发表日期
2020-12-02
DOI
10.3390/biology9120434
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effects of chronic low‐dose aspirin treatment on tumor prevention in three mouse models of intestinal tumorigenesis
- (2020) Nadine Rohwer et al. Cancer Medicine
- Tumor-derived prostaglandin E2 promotes p50 NF-κB-dependent differentiation of monocytic MDSC
- (2020) Chiara Porta et al. CANCER RESEARCH
- The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer
- (2020) Naoko Komura et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Effect of Low-dose and Standard-dose Aspirin on PGE2 Biosynthesis Among Individuals with Colorectal Adenomas: a Randomized Clinical Trial
- (2020) David A. Drew et al. Cancer Prevention Research
- ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages
- (2020) Jinlong Yin et al. Nature Communications
- Association of aspirin, metformin, and statin use with gastric cancer incidence and mortality: A nationwide cohort study
- (2020) Mi Hee Cho et al. Cancer Prevention Research
- Astrocyte Signaling in the Neurovascular Unit After Central Nervous System Injury
- (2019) Lena Huang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- GM-CSF Promotes Antitumor Immunity by Inducing Th9 Cell Responses
- (2019) Il-Kyu Kim et al. Cancer Immunology Research
- Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for PIK3CA-altered head and neck cancer
- (2019) Matthew L. Hedberg et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells
- (2019) Cristina Travelli et al. CANCER RESEARCH
- Small‐molecule inhibition of prostaglandin E receptor 2 impairs cyclooxygenase‐associated malignant glioma growth
- (2019) Jiange Qiu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer
- (2019) Vahid Karpisheh et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Human Pancreatic Carcinoma-Associated Fibroblasts Promote Expression of Co-inhibitory Markers on CD4+ and CD8+ T-Cells
- (2019) Laia Gorchs et al. Frontiers in Immunology
- Prostaglandin E2 Induces MIR675-5p to Promote Colorectal Tumor Metastasis via Modulation of p53 Expression
- (2019) Bo Cen et al. GASTROENTEROLOGY
- Low-dose aspirin use and cancer-specific mortality: a meta-analysis of cohort studies
- (2019) Xianmin Wang et al. JOURNAL OF PUBLIC HEALTH
- Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial
- (2019) Nalinie Joharatnam-Hogan et al. Lancet Gastroenterology & Hepatology
- Prostaglandin E2/EP Signaling in the Tumor Microenvironment of Colorectal Cancer
- (2019) Rei Mizuno et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A review on mPGES-1 inhibitors: From preclinical studies to clinical applications
- (2019) Filip Bergqvist et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Trends in the contemporary incidence of colorectal cancer and patient characteristics in the United Kingdom: a population-based cohort study using The Health Improvement Network
- (2018) Lucía Cea Soriano et al. BMC CANCER
- NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
- (2018) Jan P. Böttcher et al. CELL
- The multifaceted link between inflammation and human diseases
- (2018) Peramaiyan Rajendran et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Role of prostanoids in gastrointestinal cancer
- (2018) Dingzhi Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Prostaglandin E2 receptor EP4 is involved in the cell growth and invasion of prostate cancer via the cAMP‑PKA/PI3K‑Akt signaling pathway
- (2018) Song Xu et al. Molecular Medicine Reports
- Prostaglandin E2 Inhibits Prostate Cancer Progression by Countervailing Tumor Microenvironment-Induced Impairment of Dendritic Cell Migration through LXRα/CCR7 Pathway
- (2018) Kuang Youlin et al. Journal of Immunology Research
- Celecoxib in Cancer Therapy and Prevention – Review
- (2018) Natalia Tolloczko - Iwaniuk et al. CURRENT DRUG TARGETS
- Gastric cancer: epidemiology, prevention, and therapy
- (2018) Marino Venerito et al. HELICOBACTER
- Aspirin associated with risk reduction of secondary primary cancer for patients with head and neck cancer: A population-based analysis
- (2018) Yu-Shan Lin et al. PLoS One
- Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation
- (2018) Arum Park et al. Frontiers in Immunology
- Post‐diagnosis aspirin use and survival in veterans with head and neck cancer
- (2018) Catherine J. Lumley et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Prostaglandin E2 produced by myeloid-derived suppressive cells induces cancer stem cells in uterine cervical cancer
- (2018) Hiromasa Kuroda et al. Oncotarget
- Celecoxib in breast cancer prevention and therapy
- (2018) Jieqing Li et al. Cancer Management and Research
- PGE 2 synthesis and signaling in malignant transformation and progression of human hepatocellular carcinoma
- (2017) Shengbing Zang et al. HUMAN PATHOLOGY
- Aspirin and the prevention of a common disease: Colorectal cancer
- (2017) Felicita Andreotti et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Intracrine prostaglandin E2 pro-tumoral actions in prostate epithelial cells originate from non-canonical pathways
- (2017) Antonio Madrigal-Martínez et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Linking of mPGES-1 and iNOS activates stem-like phenotype in EGFR-driven epithelial tumor cells
- (2017) Erika Terzuoli et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- COX2/mPGES1/PGE2pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells
- (2017) Victor Prima et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Maintenance use of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk
- (2017) Yuanjun Ma et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Indoleamine 2,3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma
- (2017) Kashif Asghar et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Role of Aspirin in Breast Cancer Survival
- (2017) Wendy Y. Chen et al. Current Oncology Reports
- PGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells
- (2017) Lorenzo Bazzani et al. Oncotarget
- Fibroblastic reticular cells of the lymphoid tissues modulate T cell activation threshold during homeostasis via hyperactive cyclooxygenase-2/prostaglandin E2 axis
- (2017) Miao Yu et al. Scientific Reports
- Prostaglandin E2 Leads to the Acquisition of DNMT3A-Dependent Tolerogenic Functions in Human Myeloid-Derived Suppressor Cells
- (2017) Javier Rodríguez-Ubreva et al. Cell Reports
- Myeloid-Derived Suppressor Cells
- (2017) Dmitry I. Gabrilovich Cancer Immunology Research
- Constitutive IDO1 Expression in Human Tumors Is Driven by Cyclooxygenase-2 and Mediates Intrinsic Immune Resistance
- (2017) Marc Hennequart et al. Cancer Immunology Research
- Oncolytic Virus-Mediated Targeting of PGE 2 in the Tumor Alters the Immune Status and Sensitizes Established and Resistant Tumors to Immunotherapy
- (2016) Weizhou Hou et al. CANCER CELL
- PIK3CA Mutation, Aspirin Use after Diagnosis and Survival of Colorectal Cancer. A Systematic Review and Meta-analysis of Epidemiological Studies
- (2016) L. Paleari et al. CLINICAL ONCOLOGY
- Meta-analysis of aspirin use and risk of lung cancer shows notable results
- (2016) Friederike Hochmuth et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- One Niche to Rule Both Maintenance and Loss of Stemness in HSCs
- (2016) Motonari Kondo IMMUNITY
- Aspirin and Cancer
- (2016) Paola Patrignani et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dendritic cells as gatekeepers of tolerance
- (2016) Ari Waisman et al. Seminars in Immunopathology
- Prostaglandin E2 (PGE2) promotes proliferation and invasion by enhancing SUMO-1 activity via EP4 receptor in endometrial cancer
- (2016) Jieqi Ke et al. TUMOR BIOLOGY
- Linking microsomal prostaglandin E synthase-1/PGE-2 pathway with miR-15a and -186 expression: Novel mechanism of VEGF modulation in prostate cancer
- (2016) Erika Terzuoli et al. Oncotarget
- Differential expression of cyclooxygenase-2 in metastatic melanoma affects progression free survival
- (2016) Elisabetta Panza et al. Oncotarget
- IFN -Dependent Interactions between ICAM-1 and LFA-1 Counteract Prostaglandin E2-Mediated Inhibition of Antitumor CTL Responses
- (2016) F. S. Basingab et al. Cancer Immunology Research
- Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies
- (2016) Peter C. Elwood et al. PLoS One
- The cancer burden attributable to biologic agents
- (2015) David Schottenfeld et al. ANNALS OF EPIDEMIOLOGY
- Association between aspirin use and mortality in breast cancer patients: a meta-analysis of observational studies
- (2015) Shanliang Zhong et al. BREAST CANCER RESEARCH AND TREATMENT
- Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?
- (2015) G O'Callaghan et al. BRITISH JOURNAL OF PHARMACOLOGY
- Aspirin and nonsteroidal anti-inflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: a meta-analysis
- (2015) Xuan-zhang Huang et al. CANCER CAUSES & CONTROL
- Aspirin and other non-steroidal anti-inflammatory drug prescriptions and survival after the diagnosis of head and neck and oesophageal cancer
- (2015) Tatiana V Macfarlane et al. Cancer Epidemiology
- mPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity
- (2015) Federica Finetti et al. ENDOCRINE-RELATED CANCER
- Cyclooxygenase-2 inhibitors in lung cancer treatment: Bench to bed
- (2015) Rui Liu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice
- (2015) Dingzhi Wang et al. GASTROENTEROLOGY
- Direct Melanoma Cell Contact Induces Stromal Cell Autocrine Prostaglandin E2-EP4 Receptor Signaling That Drives Tumor Growth, Angiogenesis, and Metastasis
- (2015) Masaki Inada et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lipopolysaccharide induces inflammation and facilitates lung metastasis in a breast cancer model via the prostaglandin E2-EP2 pathway
- (2015) SHANCHENG LI et al. Molecular Medicine Reports
- Role of microsomal prostaglandin E synthase-1 (mPGES-1)-derived prostaglandin E2 in colon carcinogenesis
- (2015) Yuka Sasaki et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Prostaglandin E receptor 4 (EP4) promotes colonic tumorigenesis
- (2015) Jian Chang et al. Oncotarget
- PGE2-induced colon cancer growth is mediated by mTORC1
- (2014) Marc Dufour et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Aspirin intake and breast cancer survival – a nation-wide study using prospectively recorded data in Sweden
- (2014) Michelle D Holmes et al. BMC CANCER
- Over-expression of COX-2 mRNA in colorectal cancer
- (2014) Hennie MJ Roelofs et al. BMC GASTROENTEROLOGY
- Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study
- (2014) D M Fraser et al. BRITISH JOURNAL OF CANCER
- Aspirin and non-steroidal anti-inflammatory drug use and the risk of upper aerodigestive tract cancer
- (2014) T V Macfarlane et al. BRITISH JOURNAL OF CANCER
- Activated cytotoxic lymphocytes promote tumor progression by increasing the ability of 3LL tumor cells to mediate MDSC chemoattraction via Fas signaling
- (2014) Fei Yang et al. Cellular & Molecular Immunology
- Inhibition of Tumor-Derived Prostaglandin-E2 Blocks the Induction of Myeloid-Derived Suppressor Cells and Recovers Natural Killer Cell Activity
- (2014) Y. Mao et al. CLINICAL CANCER RESEARCH
- Prostanoid induces premetastatic niche in regional lymph nodes
- (2014) Fumihiro Ogawa et al. JOURNAL OF CLINICAL INVESTIGATION
- Vascular endothelial growth factor plays a critical role in the formation of the pre-metastatic niche via prostaglandin E2
- (2014) SHILI LIU et al. ONCOLOGY REPORTS
- Prostaglandin E2 accelerates invasion by upregulating Snail in hepatocellular carcinoma cells
- (2014) Min Zhang et al. TUMOR BIOLOGY
- Low-dose aspirin use and cancer characteristics: a population-based cohort study
- (2013) F Jonsson et al. BRITISH JOURNAL OF CANCER
- Melanoma-Educated CD14 + Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2–Dependent Mechanisms
- (2013) Yumeng Mao et al. CANCER RESEARCH
- Reciprocal crosstalk between dendritic cells and natural killer cells under the effects of PGE2 in immunity and immunopathology
- (2013) Hedi Harizi Cellular & Molecular Immunology
- The ratio between dendritic cells and T cells determines whether prostaglandin E2 has a stimulatory or inhibitory effect
- (2013) Alexander Shimabukuro-Vornhagen et al. CELLULAR IMMUNOLOGY
- Expression of microsomal prostaglandin E2 synthase-1 and its role in human hepatocellular carcinoma
- (2013) Shengbing Zang et al. HUMAN PATHOLOGY
- Prostaglandin E2 promotes liver cancer cell growth by the upregulation of FUSE-binding protein 1 expression
- (2013) JUAN MA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- T and NK cells: two sides of tumor immunoevasion
- (2013) Doriana Fruci et al. Journal of Translational Medicine
- Colorectal carcinoma-derived fibroblasts modulate natural killer cell phenotype and antitumor cytotoxicity
- (2013) Tuanjie Li et al. MEDICAL ONCOLOGY
- Genetic deletion of microsomal prostaglandin E synthase-1 suppresses mouse mammary tumor growth and angiogenesis
- (2013) Louise R. Howe et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE2-mediated immunosuppression and inhibits breast cancer metastasis
- (2013) Xinrong Ma et al. OncoImmunology
- HT-29 human colon cancer cell proliferation is regulated by cytosolic phospholipase A2α dependent PGE2 via both PKA and PKB pathways
- (2012) Liz Kisslov et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO Study
- (2012) F M Shebl et al. BRITISH JOURNAL OF CANCER
- Melanoma Cells Inhibit Natural Killer Cell Function by Modulating the Expression of Activating Receptors and Cytolytic Activity
- (2012) G. Pietra et al. CANCER RESEARCH
- Modulation of Host Natural Killer Cell Functions in Breast Cancer via Prostaglandin E2 Receptors EP2 and EP4
- (2012) Dawn M. Holt et al. JOURNAL OF IMMUNOTHERAPY
- Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials
- (2012) Annemijn M Algra et al. LANCET ONCOLOGY
- Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
- (2012) Catherine de Martel et al. LANCET ONCOLOGY
- The role of aspirin in cancer prevention
- (2012) Michael J. Thun et al. Nature Reviews Clinical Oncology
- Aspirin Use, TumorPIK3CAMutation, and Colorectal-Cancer Survival
- (2012) Xiaoyun Liao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacological Inhibition of Microsomal Prostaglandin E Synthase-1 Suppresses Epidermal Growth Factor Receptor-Mediated Tumor Growth and Angiogenesis
- (2012) Federica Finetti et al. PLoS One
- Role of medical history and medication use in the aetiology of upper aerodigestive tract cancers in Europe: the ARCAGE study
- (2011) T. V. Macfarlane et al. ANNALS OF ONCOLOGY
- Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells
- (2011) N. Obermajer et al. BLOOD
- Prostaglandin catabolic enzymes as tumor suppressors
- (2011) Hsin-Hsiung Tai CANCER AND METASTASIS REVIEWS
- Non-steroidal anti-inflammatory drug and aspirin use and the risk of head and neck cancer: a systematic review
- (2011) Jessica C. Wilson et al. CANCER CAUSES & CONTROL
- Prostaglandin E2 (PGE2) suppresses natural killer cell function primarily through the PGE2 receptor EP4
- (2011) Dawn Holt et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Selective PGE2 Suppression Inhibits Colon Carcinogenesis and Modifies Local Mucosal Immunity
- (2011) M. Nakanishi et al. Cancer Prevention Research
- Lung Cancer Chemoprevention with Celecoxib in Former Smokers
- (2011) Jenny T. Mao et al. Cancer Prevention Research
- COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells
- (2011) M. Fujita et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- M2 Macrophages Induced by Prostaglandin E2 and IL-6 from Cervical Carcinoma Are Switched to Activated M1 Macrophages by CD4+ Th1 Cells
- (2011) M. Heusinkveld et al. JOURNAL OF IMMUNOLOGY
- EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicity
- (2011) S Donnini et al. ONCOGENE
- PGE2 inhibits natural killer and γδ T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling
- (2010) Ludovic Martinet et al. BIOCHEMICAL PHARMACOLOGY
- Pre-surgical study of the biological effects of the selective cyclo-oxygenase-2 inhibitor celecoxib in patients with primary breast cancer
- (2010) Lesley-Ann Martin et al. BREAST CANCER RESEARCH AND TREATMENT
- Nonsteroidal Anti-Inflammatory Drugs and Risk for Ovarian and Endometrial Cancers in the Iowa Women's Health Study
- (2010) A. E. Prizment et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Biological Activity of Celecoxib in the Bronchial Epithelium of Current and Former Smokers
- (2010) E. S. Kim et al. Cancer Prevention Research
- Inhibition of Hypoxia Inducible Factor-1 by Dihydroxyphenylethanol, a Product from Olive Oil, Blocks Microsomal Prostaglandin-E Synthase-1/Vascular Endothelial Growth Factor Expression and Reduces Tumor Angiogenesis
- (2010) E. Terzuoli et al. CLINICAL CANCER RESEARCH
- Role of prostanoid IP and EP receptors in mediating vasorelaxant responses to PGI2 analogues in rat tail artery: Evidence for Gi/o modulation via EP3 receptors
- (2010) Nelson N. Orie et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Prostaglandin E2 Signaling and Bacterial Infection Recruit Tumor-Promoting Macrophages to Mouse Gastric Tumors
- (2010) Hiroko Oshima et al. GASTROENTEROLOGY
- Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
- (2010) Peter M Rothwell et al. LANCET
- Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function
- (2010) Thomas Condamine et al. TRENDS IN IMMUNOLOGY
- Prostaglandin E 2 Primes the Angiogenic Switch via a Synergic Interaction With the Fibroblast Growth Factor-2 Pathway
- (2009) Federica Finetti et al. CIRCULATION RESEARCH
- Aspirin Use and the Risk of Gastric Cancer: A Meta-Analysis
- (2009) Ping Yang et al. DIGESTIVE DISEASES AND SCIENCES
- Aspirin for the Chemoprevention of Colorectal Adenomas: Meta-analysis of the Randomized Trials
- (2009) Bernard F. Cole et al. JNCI-Journal of the National Cancer Institute
- Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement
- (2009) Jack Cuzick et al. LANCET ONCOLOGY
- 15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors
- (2009) M. Yan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Aspirin: Promise and Resistance in the New Millennium
- (2008) Carlo Patrono et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Human natural killer cells
- (2008) M. A. Caligiuri BLOOD
- Celecoxib and exemestane versus placebo and exemestane in postmenopausal metastatic breast cancer patients: a double-blind phase III GINECO study
- (2008) C. Falandry et al. BREAST CANCER RESEARCH AND TREATMENT
- Association between NSAIDs use and breast cancer risk: a systematic review and meta-analysis
- (2008) Ya-shuang Zhao et al. BREAST CANCER RESEARCH AND TREATMENT
- Antagonism of the prostaglandin E receptor EP4 inhibits metastasis and enhances NK function
- (2008) Namita Kundu et al. BREAST CANCER RESEARCH AND TREATMENT
- Genetic Deletion of mPGES-1 Suppresses Intestinal Tumorigenesis
- (2008) M. Nakanishi et al. CANCER RESEARCH
- Prostaglandin E2 Regulates Tumor Angiogenesis in Prostate Cancer
- (2008) S. Jain et al. CANCER RESEARCH
- Induction of myeloid-derived suppressor cells by tumor exosomes
- (2008) Xiaoyu Xiang et al. INTERNATIONAL JOURNAL OF CANCER
- Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer
- (2008) Louis Wing-Cheong Chow et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now